Our prospective radiomics study demonstrates that ultrafast MRI exhibits superior classification performance for breast cancer HER2 status and molecular subtype compared to standard MRI for radiologists of different experience levels (a dedicated breast radiologist and a radiology resident). The gene discussed is ERBB2; the disease is breast cancer.